University Of Pennsylvania
Clinical trials sponsored by University Of Pennsylvania, explained in plain language.
-
New myeloma drug trial halted early – what we know
Disease control TerminatedThis early-stage study tested a drug called tasquinimod in people with multiple myeloma that had returned or stopped responding to prior treatments. The goal was to find a safe dose and check for side effects when given alone or with standard therapy. The trial was stopped early,…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC
-
Experimental CAR t therapy for pancreatic cancer shows early promise but trial halted
Disease control TerminatedThis early-phase study tested a new immune therapy called CAR T cells in people with advanced pancreatic cancer that could not be removed by surgery. The goal was to see if the treatment was safe and feasible. The trial was terminated early, so results are limited.
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC
-
Heart pump combo shows promise in shock, but study cut short
Disease control TerminatedThis study looked at people in cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. All patients were on a machine called VA-ECMO to support their heart and lungs. The study tested if adding another device, Impella CP, to directly unload the he…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 01, 2026 17:54 UTC
-
Brain scan study aims to unlock secrets of consciousness
Knowledge-focused TerminatedThis study tested whether a special type of brain scan (resting state fMRI) could help doctors better understand and predict recovery in patients with disorders of consciousness, such as coma. Nine adults with these conditions were enrolled. The goal was to see if the scans could…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 11, 2026 11:57 UTC
-
Botswana study investigates tamoxifen adherence in breast cancer patients
Knowledge-focused TerminatedThis study looked at why women with breast cancer in Botswana might stop taking tamoxifen, a key hormone therapy. Researchers focused on side effects, quality of life, and HIV status as possible reasons. The study included 10 women, both with and without HIV, to understand barrie…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 05, 2026 12:08 UTC